Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

NCT00716742 · clinicaltrials.gov ↗

COMPLETED

Status

1099

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004%

Sponsor

Allergan